CompletedNot Applicable

Accelerated Resolution Therapy for Complicated Grief

United States54 participantsStarted 2018-02-20

Plain-language summary

This study will examine whether accelerated resolution therapy (ART) is effective for the treatment of prolonged and complicated grief and associated psychological trauma among older adult hospice caregivers who have experienced the death of an immediate family member at least 12 months ago.

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult age 60 years of age or older * previous primary caregiver of immediate family member who died after enrollment in hospice with the death occurring at least 12 months prior to enrollment * current symptoms indicative of proposed diagnostic criteria for complicated grief disorder, as proposed by Shear et al. (2011) * current score of \>25 on the 19-item Inventory of Complicated Grief * current symptoms indicative of significant psychological trauma, as documented by score \>33on the 20-item DSM-5 PTSD checklist (PCL-5)26 or score \>4 on the PDSQ PTSD subscale * denial of suicidal ideation or intent, with no evidence of psychotic behavior Exclusion Criteria: * engaged in another psychotherapy regimen that could also influence symptoms of PCG - - major psychiatric disorder (e.g. bipolar disorder) deemed likely to interfere with treatment delivery * current substance abuse dependence (alcohol and/or drug) treatment anticipated to interfere with treatment delivery.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

change in complicated grief symptoms

Timeframe: 4 weeks, follow up at 12 weeks

change in psychological trauma

Timeframe: 4 weeks, follow up at 12 weeks

change in depressive symptoms

Timeframe: 4 weeks, follow up at 12 weeks

Trial details

NCT IDNCT03484338

SponsorUniversity of South Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-07-31

View on ClinicalTrials.gov More Grief trials

Who can participate

Age range

60 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.